MedWatch

Bank of America prefers Sonova to GN and Demant

In its revived coverage of hearing aid companies, the US-based bank has cooled off on Danish companies Demant and GN Group and is more excited by Swiss Sonova.

Photo: Demant / PR

Bank of America has brought back its coverage of the hearing aid industry, starting off with a ”buy” recommendation for Swiss Sonova, according to PLX.AI.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs